Upadacitinib
- PDF / 168,741 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 5 Downloads / 173 Views
1 S
Herpes zoster meningitis: case report In an analysis of patients with rheumatoid arthritis treated under five trials until 30 June 2019, a patient [age and sex not stated] was described, who developed herpes zoster meningitis during the treatment with oral upadacitinib 30mg daily for rheumatoid arthritis [duration of treatment to reaction onset and outcome not stated]. Winthrop K, et al. Incidence and risk factors for herpes zoster in rheumatoid arthritis patients receiving upadacitinib. Annals of the Rheumatic Diseases 79 (Suppl. 1): 335-336 803516093 abstr. THU0218, Jun 2020. Available from: URL: https://ard.bmj.com/content/79/Suppl_1/335 [abstract]
0114-9954/20/1831-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 21 Nov 2020 No. 1831
Data Loading...
